Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR
This clinical trial update reports ongoing recruitment for a study evaluating MR-guided cognitive distraction and relaxation therapy for pai…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Sensorial Discrimination in Chronic Low Back Pain [NA]
Completed clinical trial evaluating sensorial discrimination in chronic low back pain.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse [NA]
This is a clinical trial update for a pilot study of a combined treatment approach for veterans with chronic pain and problematic opioid use…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Marijuana in Combination With Opioids in Palliative and Hospice Patients [Phase 1]
Phase 1 clinical trial evaluating the safety and effects of combining marijuana with opioids for pain management in palliative and hospice p…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
This clinical trial update notes a completed study investigating chronic pain, opioid use, and epidermal nerve fiber density.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Learning to Apply Mindfulness to Pain [NA]
This clinical trial investigating mindfulness-based techniques for chronic pain has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Dosing of Ketorolac in the Emergency Department [Phase 4]
A Phase 4 trial evaluating dosing of ketorolac for acute pain in the emergency department was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Online "Pain, Stress & Emotions" Class in Chronic Pain [EARLY_Phase 1]
This entry reports the completion of an EARLY_PHASE1 clinical trial evaluating an online program addressing pain, stress, and emotions for i…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Preventing Pain After Heart Surgery [Phase 4]
Phase 4 clinical trial update indicating completion of a study on preventing postoperative pain after heart surgery.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: VR Solace for Pain and Anxiety Using Survey and Biodata [NA]
A completed clinical trial evaluating VR Solace for chronic pain and associated anxiety has posted results.
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) [Phase 2]
This item describes a Phase 2 clinical trial evaluating CBOT-P, a computerized chemosensory-based orbitofrontal networks training for treati…
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals’ generic oxycodone/acetaminophen product.
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for HYDROCODONE BITARTRATE AND ACETAMINOPHEN by Amneal Pharmaceuticals LLC.
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Aurolife Pharma, LLC. This action approv…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., granting approval for the gener…
-
FDA approval · 2024-10-31FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for tapentadol hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for oxycodone and acetaminophen (OXYCODONE AND ACETAMINOPHEN) from Amneal Pharmaceuticals of New Yor…
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for the combination product hydrocodone bitartrate and ibuprofen submitted by Amneal Pharmaceuticals…
-
FDA approval · 2024-10-31FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (SpecGx LLC)
The FDA approved a Supplemental Application for Acetaminophen and Codeine Phosphate from SpecGx LLC, indicating a regulatory action on this …
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Elite Laboratories, Inc., under an ANDA. This action updates th…
-
FDA approval · 2024-10-31FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the pentazocine and naloxone combination (pentazocine hydrochloride and naloxone hydrochloride) …
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for oxycodone hydrochloride by Epic Pharma, LLC, authorizing the generic product. Oxycodone hydrochl…
-
FDA approval · 2024-10-31FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Supplemental Application (Ascent Pharmaceuticals Inc)
FDA approved a supplemental application for hydromorphone hydrochloride from Ascent Pharmaceuticals Inc. The action confirms regulatory appr…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved Camber Pharmaceuticals' supplemental application for methadone hydrochloride, a generic product. This confirms regulatory clear…
-
FDA approval · 2024-10-31FDA Approved: BUPRENORPHINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for buprenorphine submitted by Teva Pharmaceuticals USA, Inc., indicating an approved update to …